MARKET

AMRS

AMRS

Amyris Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.065
+0.135
+6.99%
Opening 13:20 07/05 EDT
OPEN
1.890
PREV CLOSE
1.930
HIGH
2.085
LOW
1.795
VOLUME
2.86M
TURNOVER
2.64M
52 WEEK HIGH
16.99
52 WEEK LOW
1.466
MARKET CAP
660.21M
P/E (TTM)
-6.8856
1D
5D
1M
3M
1Y
5Y
Amyris among Energy/Material gainers; NexTier Oilfield and Resolute Forest Products among losers
Gainers: Loop Industries (LOOP) +12%. Zymergen (<a href="https://s...
Seekingalpha · 1h ago
Could The Amyris, Inc. (NASDAQ:AMRS) Ownership Structure Tell Us Something Useful?
The big shareholder groups in Amyris, Inc. ( NASDAQ:AMRS ) have power over the company. Large companies usually have...
Simply Wall St. · 2d ago
EATV, the World's First Plant-based Innovation ETF, Makes History at The New York Stock Exchange (NYSE: EATV)
EATV (NYSE: EATV), the VegTech™ Plant-based Innovation & Climate ETF, made history on June 23rd, when its advisor, VegTech™ Invest, threw a party at The New York Stock Exchange celebrating the listing of the world's first Plant-based Innovation ETF.
PR Newswire · 06/27 12:00
Materials weekly round-up: Danimer Scientific take #1 spot; 5E Advanced Materials slides to bottom
The material sector closed this trading week in green, with S&P 500 Materials registering 2.53% gain and the Materials Select Sector SPDR ETF (NYSEARCA:XLB) up 2.07%. Iron ore prices fell over 8% on
Seekingalpha · 06/25 16:26
AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has successfully started fermentation at its new pr...
PR Newswire · 06/23 12:00
Amyris Chief Accounting Officer Anthony Hughes Resigns
MT Newswires · 06/15 16:41
Materials Sector Weekly Round-up: Ramaco tops winners; FEAM drops to bottom
The S&P Materials sector closed the trading week in red at -6.73% as copper and other industrial metals fell in the wake of recession concerns and renewed COVID-19 restrictions in China. The
Seekingalpha · 06/11 19:33
41 Stocks Moving In Friday's Mid-Day Session
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
Benzinga · 05/27 18:13
More
No Data
Learn about the latest financial forecast of AMRS. Analyze the recent business situations of Amyris Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

25.00%Strong Buy
50.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AMRS stock price target is 11.76 with a high estimate of 22.00 and a low estimate of 2.500.
High22.00
Average11.76
Low2.500
Current 2.125
EPS
Actual
Estimate
-0.26-0.15-0.040.08
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 267
Institutional Holdings: 151.46M
% Owned: 47.37%
Shares Outstanding: 319.71M
TypeInstitutionsShares
Increased
68
17.59M
New
31
6.29M
Decreased
74
13.16M
Sold Out
39
6.08M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Commodity Chemicals
-2.95%
Chemicals
-2.99%
Key Executives
Non-Executive Chairman/Independent Director
Geoffrey Duyk
Chief Executive Officer/President/Director
John Melo
Chief Financial Officer/Chief Administrative Officer
Han Kieftenbeld
Chief Operating Officer
Eduardo Alvarez
Secretary
Nicole Kelsey
Director
Philip Eykerman
Director
Ryan Panchadsaram
Independent Director
John Doerr
Independent Director
Ana Dutra
Independent Director
Frank Kung
Independent Director
James Mccann
Independent Director
Steven Mills
Independent Director
Lisa Qi
Independent Director
Julie Washington
No Data
No Data
About AMRS
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.

Webull offers kinds of Amyris Inc stock information, including NASDAQ:AMRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRS stock methods without spending real money on the virtual paper trading platform.